Mspempyqzqudl1i3lpwq screen shot 2018 02 04 at 18.02.43

Imavita

ic No Reviews Yet
ic No Completed Orders
Ramonville Saint Agne, FR

About Imavita

Founded: 2013 Type: Partnership Size: 1-10 employees

Imavita is an innovating technology company proposing preclinical services in the exploration of preclinical models of human pathologies by the use of innovating imaging techniques.
The vision of our company is to propose to pharmaceutical industries, biotechnology companies and other private & public... Show more »

Imavita is an innovating technology company proposing preclinical services in the exploration of preclinical models of human pathologies by the use of innovating imaging techniques.
The vision of our company is to propose to pharmaceutical industries, biotechnology companies and other private & public laboratories, innovating solutions in efficacy / toxicity evaluation of active ingredients in laboratory species by the use of non invasive imaging techniques and appropriate imaging analysis for quantitative evaluation of specific imaging biomarkers.

Imavita is actually developing the following tools:
- Pre-clinical testing in laboratory species (induction of pathologies / treatment & sampling phases)
- Imaging techniques like SPECT/CT, CT with Single/Dual Energy CT approach, MRI, ultrasonography, etc…
- Images exploitation and analysis for quantitative imaging

Imavita is planning to focus its activities in the following domains:
- Cardiovascular diseases
- Osteo-articular pathologies
- Dermatology
- Oncology
- Neurology
- Drug disposition / PK
- Medical Devices

Imavita is member of AFSSI (“Association Française des Sociétés de Services et d’Innovation pour les Sciences de la Vie” / French association of innovating services companies in life sciences)

Imavita is ISO9001 certified.

Show less

Our Services (7)


ic

In vivo Drug Efficacy Testing

Price on request

Imavita proposes preclinical models which can be used alone or associated with imaging modalities to permit the evaluation of efficacy of new compounds / new therapeutics treatments in development phase.

Species / strains
- Rodents (rat / mouse / hamster / Guinea pig)
- Non rodents (rabbits / pig / sheep / goat)
- Fish... Show more »

Imavita proposes preclinical models which can be used alone or associated with imaging modalities to permit the evaluation of efficacy of new compounds / new therapeutics treatments in development phase.

Species / strains
- Rodents (rat / mouse / hamster / Guinea pig)
- Non rodents (rabbits / pig / sheep / goat)
- Fish (zebra fish)
- Healthy / normal models

Type of studies
- Pharmacokinetics / early PK
- Pharmacodynamics / PK/PD relationships
- Biodistribution / Elimination evaluation

Example of projects
- PK / early PK / PK/PD with serial or terminal sampling animals (in-life phase)
- PK on catheterized animals (jugular / femoral / combined) for PK and/or PK/PD studies (in-life phase)
- Bile / lymph / cerebrospinal fluid catheterized rats for pharmacokinetics evaluation / transport evaluation of molecules / PK/PD relationships (in-life phase)
- Telemetry studies (core temperature / ECG / EMG /EEG) combined or not with catheterized animals for PK/PD evaluation or safety pharmacology
- Pathological models / induced pathologies

Type of studies
- Evaluation of pharmacokinetics on pathological animals / impact of pathology on PK parameters
- Efficacy studies with different approaches:
- Classical approach / parallel groups
- Longitudinal study (repeated measure experiment) by applying imaging modalities

Example of projects
- Efficacy studies in myocardial infarction induced rat
- Efficacy of new molecules on bone healing in normal & osteoporosis rat model
- Efficacy of new molecules on skin healing (wound / burn in mice or rat)

Resources
- Access to conventional facilities / SPF / SOPF for rodents
- Access to conventional facilities for large species

Show less

ic

PBPK Modeling

In silico absorption, distribution, metabolism, and excretion
Price on request

Imavita proposes preclinical models which can be used alone or associated with imaging modalities to permit the evaluation of efficacy of new compounds / new therapeutics treatments in development phase.

Species / strains
- Rodents (rat / mouse / hamster / Guinea pig)
- Non rodents (rabbits / pig / sheep / goat)
- Fish... Show more »

Imavita proposes preclinical models which can be used alone or associated with imaging modalities to permit the evaluation of efficacy of new compounds / new therapeutics treatments in development phase.

Species / strains
- Rodents (rat / mouse / hamster / Guinea pig)
- Non rodents (rabbits / pig / sheep / goat)
- Fish (zebra fish)
- Healthy / normal models

Type of studies
- Pharmacokinetics / early PK
- Pharmacodynamics / PK/PD relationships
- Biodistribution / Elimination evaluation

Example of projects
- PK / early PK / PK/PD with serial or terminal sampling animals (in-life phase)
- PK on catheterized animals (jugular / femoral / combined) for PK and/or PK/PD studies (in-life phase)
- Bile / lymph / cerebrospinal fluid catheterized rats for pharmacokinetics evaluation / transport evaluation of molecules / PK/PD relationships (in-life phase)
- Telemetry studies (core temperature / ECG / EMG /EEG) combined or not with catheterized animals for PK/PD evaluation or safety pharmacology
- Pathological models / induced pathologies

Type of studies
- Evaluation of pharmacokinetics on pathological animals / impact of pathology on PK parameters
- Efficacy studies with different approaches:
- Classical approach / parallel groups
- Longitudinal study (repeated measure experiment) by applying imaging modalities

Example of projects
- Efficacy studies in myocardial infarction induced rat
- Efficacy of new molecules on bone healing in normal & osteoporosis rat model
- Efficacy of new molecules on skin healing (wound / burn in mice or rat)

Resources
- Access to conventional facilities / SPF / SOPF for rodents
- Access to conventional facilities for large species

Show less

ic

ADME/DMPK Studies

Drug Metabolism and Pharmacokinetics
Price on request
Request a quote for more information about this service.

ic

Pharmacology & Toxicology

Price on request
Request a quote for more information about this service.

ic

Microscopy

Price on request
Request a quote for more information about this service.

ic

Imaging & Spectroscopy

Price on request
Request a quote for more information about this service.

ic

Safety Pharmacology

Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
Missing Avatar

Eric Lacoste

CEO/CSO

Imavita has not received any reviews.

Imavita has not received any endorsements.